| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.006 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.008 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |